[Onerous treatments. Adalimumab: Humira].
Levang
J
J
Service de dermatologie, CHU de Besançon, 2 place Saint-Jacques, Besançon cedex, France.
Aubin
F
F
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D003711:Demyelinating Diseases / Q000139:chemically induced; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007239:Infections / Q000139:chemically induced; D009369:Neoplasms / Q000139:chemically induced; D011565:Psoriasis / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D000068879:Adalimumab